Runben Biotechnology Co., Ltd. (SHA:603193)
24.51
+0.66 (2.77%)
Apr 15, 2026, 3:00 PM CST
-31.23% (1Y)
| Market Cap | 9.92B -26.9% |
| Revenue (ttm) | 1.52B +21.8% |
| Net Income | 305.33M -0.3% |
| EPS | 0.76 -0.1% |
| Shares Out | 404.59M |
| PE Ratio | 32.29 |
| Forward PE | 29.41 |
| Dividend | 0.46 (1.93%) |
| Ex-Dividend Date | n/a |
| Volume | 5,754,078 |
| Average Volume | 5,044,050 |
| Open | 23.86 |
| Previous Close | 23.85 |
| Day's Range | 23.61 - 24.55 |
| 52-Week Range | 20.28 - 44.00 |
| Beta | 0.18 |
| RSI | 58.63 |
| Earnings Date | Apr 23, 2026 |